28 September: The City of Oslo to offer a choice of coronavirus vaccines

Press release: From Wednesday 29 September, residents over the age of 16 can choose which mRNA vaccine they want to receive for their first and second doses. The same applies to people with impaired immune systems who are due to receive a third dose. This decision was taken after the Norwegian Institute of Public Health informed district medical officers that adults can choose the type of vaccine they wish to receive wherever this can be arranged by the relevant local authority, as Norway currently has a good supply of both types of mRNA vaccine (BioNtech/Pfizer and Moderna).

Les pressemeldingen på norsk

"We currently have sufficient levels of both the BioNtech/Pfizer and Moderna vaccines in stock to last until mid-October. This means we can allow residents to choose which type of vaccine they want to receive," says Head of the City of Oslo's vaccination programme, Miert Skjoldborg Lindboe.

"Both types of vaccine offered are effective in preventing severe coronavirus infection and death, and can be safely combined. We hope that this will contribute to even higher vaccination coverage in the City of Oslo," Lindboe continues.

If residents wish to have a type of vaccine that the centre cannot offer on the day they attend, they can arrange an appointment for another day when the vaccine in question will be available. We cannot guarantee how long the various types of vaccine will be in stock, so we recommended that you attend your local vaccination centre in the near future.

Oslo will continue to mainly offer the BioNtech/Pfizer vaccine to all young people under the age of 18. Both types of vaccine have been approved for everyone over the age of 12.